Compound information
- Natural Products
- ZC3400949
- Molecular Formula
- C33H34FN7O3
- Molecular Weight
- 595.270716168 g/mol
- Structure
-
- IUPAC Name
- 3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-N-[4-[[4-(3-fluoro-5-morpholino-phenyl)pyrimidin-2-yl]amino]phenyl]benzamide
- InChI
- InChI=1S/C33H34FN7O3/c1-40(2)14-4-7-31(42)36-28-6-3-5-23(20-28)32(43)37-26-8-10-27(11-9-26)38-33-35-13-12-30(39-33)24-19-25(34)22-29(21-24)41-15-17-44-18-16-41/h3-13,19-22H,14-18H2,1-2H3,(H,36,42)(H,37,43)(H,35,38,39)/b7-4+
- InChI Key
- FGMLVABPTLYAKF-QPJJXVBHSA-N
- SMILES
- CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cc(F)cc(N5CCOCC5)c4)n3)cc2)c1
- Source
- ZINC001875380099
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 44 | Ring Count | 5 |
Heteroatom Count | 11 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 111.72 Å2 | LogP | 4.537 |
LogS | -5.501 | LogD | 3.813 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.232 | Pgp substrate | 0.794 |
HIA | 0.969 | F20 % | 0.965 |
F30 % | 0.202 | Caco-2 | -5.148 |
MDCK | -5.469 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.001 | PPB | 94.295 |
VD | 1.664 | Fu | 1.895 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.901 | CYP1A2 substrate | 0.544 |
CYP2A6 substrate | 0.112 | CYP2B6 substrate | 0.425 |
CYP2C19 inhibitor | 0.074 | CYP2C19 substrate | 0.901 |
CYP2C8 substrate | 0.919 | CYP2C9 inhibitor | 0.008 |
CYP2C9 substrate | 0.004 | CYP2D6 inhibitor | 0.19 |
CYP2D6 substrate | 0.87 | CYP2E1 substrate | 0.152 |
CYP3A4 inhibitor | 0.864 | CYP3A4 substrate | 0.957 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.146 | CL | 5.757 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.231 | Hepatotoxicity | 0.992 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.069 |
FDAMDD | 0.904 | Skin Sensitization | 0.687 |
Carcinogenicity | 0.423 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.905 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.343 | IGC50 | 4.882 |
LC50FM | -8.223 | LC50DM | -3.507 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.586 | NR-AR-LBD | 0.519 |
NR-AhR | 0.95 | NR-Aromatase | 0.606 |
NR-ER | 0.817 | NR-ER-LBD | 0.653 |
NR-PPAR-gamma | 0.928 | SR-ARE | 0.961 |
SR-ATAD5 | 0.901 | SR-HSE | 0.645 |
SR-MMP | 0.956 | SR-p53 | 0.932 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.